Latest TAK reports update at 2022-06-29: 2022-Q1 ∙ 2021-Q1

Takeda Pharmaceutical Company Limited TAK

$ 13.37 2.45%

Takeda Pharmaceutical Company Limited Financial Statements 2011-2024 | TAK

Annual Financial Statements Takeda Pharmaceutical Company Limited

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	20.3 B	56.2 B	35.2 B	33.1 B	38.8 B	37.6 B	40.4 B	35.3 B	43 B	34.3 B	38.3 B
Shares	1.56 B	3.13 B	1.92 B	1.56 B	1.56 B	1.57 B	1.57 B	1.58 B	1.58 B	1.58 B	1.58 B
Historical Prices	13.6	18.2	18.8	15.3	25	17.7	20.6	16.6	17.8	16.5	15.7
Net Income	376 B	44.2 B	109 B	187 B	115 B	80.2 B	-146 B	107 B	131 B	124 B	248 B
Revenue	3.2 T	3.29 T	2.1 T	1.77 T	1.73 T	1.81 T	1.78 T	1.69 T	1.56 T	1.51 T	1.42 T
Cost of Revenue	994 B	1.09 T	652 B	496 B	559 B	-	-	-	-	-	-
Gross Profit	-	2.2 T	1.44 T	1.27 T	1.17 T	1.27 T	1.26 T	1.2 T	1.11 T	1.08 T	1.1 T
Operating Income	509 B	100 B	238 B	242 B	156 B	-	-	-	-	-	-
Interest Expense	131 B	149 B	48.2 B	10 B	7.56 B	-	-	-	-	-	-
EBITDA	509 B	722 B	358 B	364 B	313 B	256 B	47.1 B	282 B	324 B	415 B	474 B
Operating Expenses	-	1.94 T	1.28 T	1.03 T	1.02 T	1.14 T	1.39 T	1.06 T	987 B	811 B	735 B
General and Administrative Expenses	-	965 B	718 B	628 B	619 B	651 B	613 B	556 B	812 B	811 B	640 B

All numbers in JPY currency

Quarterly Income Statement Takeda Pharmaceutical Company Limited

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in JPY currency